Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVL vs Carvedilol for Prevention of First Variceal Bleeding in HCC
NCT06594744Phase 4Recruiting
- Sponsor
- Taipei Veterans General Hospital
- Start
- Oct 2024
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in esophageal varices, sponsored by Taipei Veterans General Hospital. Started Oct 2024; status: recruiting.
02
Drugs
carvedilol
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT06594744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06594744.